Denali Therapeutics 10K 2020 Annual report | DNLI Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: AAV, AB, adult, afflict, Amylyx, antisense, ARSA, attenuating, authoritative, behavior, Biden, BIG, BIMA, BioArtic, biomedical, black, bone, Brexit, bulk, cartilage, cast, cerebrospinal, circle, CLE, constipation, contact, contractor, contradicted, counterpart, CPRA, depressing, depression, distancing, dominated, durability, durable, eighteen, envision, epidemic, Eukaryotic, faith, flexibility, frontal, FY, GAA, Gaucher, Gehrig, geographic, globe, granulin, heightening, home, IDUA, IFN, IIIB, infected, infection, infiltration, Inspector, interface, JDC, judgement, Kingdom, leader, lesser, Leukodystrophy, Lou, lung, magnitude, median, memory, Metachromatic, MHRA, MLD, monoacylglycerol, monogenic, multiregional, muscle, NAGLU, nationwide, neurobehavioral, neurocognitive, neuromuscular, neuronopathic, NIBSC, Northern, nurse, oligonucleotide, Orchard, OTV, outbreak, outset, overlay, overview, pandemic, parliamentary, pathophysiology, pause, paused, perspective, Pompe, preparatory, President, prespecified, quarantine, remotely, resumed, ROFN, Secarna, shelter, shipping, situation, skeletal, SPA, spanning, Squibb, subset, supersede, superseded, tailored, temporal, thirty, tie, Trump, unnamed, unprecedented, upcoming, vision, walking, weekly, window

Removed: affiliate, affinity, annum, ArmaGen, Celgene, characterizing, classifying, close, concurrently, convert, converted, disrupting, dissolution, dual, financed, firmly, freestanding, inclusion, intracellular, involuntary, judged, location, maturation, modulating, neuronal, par, participated, preferential, pro, PTO, rata, ratably, readout, reclassification, reclassified, redeemed, reorganization, retroactively, Sage, summarize, toxic, trafficking, tranche, Unaudited, unpaid, Voyager


Subsidiary Name						Jurisdiction of Incorporation or Organization
Denali BBB Holding Limited						United Kingdom

Denali Therapeutics (DNLI) 10-K2020 FY Annual report

Content analysis